DEBORAH CHANDLER: Open Payments
NPI 1861696247 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,029 in 11 payments from 8 companies in 2025. Trend: 2023 $20,069 · 2024 $3,948 · 2025 $4,029
Speaker / faculty: $3,450Food & beverage: $429Consulting: $150
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. | 4 | $3,520 |
| Biogen, Inc. | 1 | $150 |
| Eisai Inc. | 1 | $120 |
| GENZYME CORPORATION | 1 | $96 |
| Celgene Corporation | 1 | $41 |
| Cala Health, Inc. | 1 | $39 |
| Novartis Pharmaceuticals Corporation | 1 | $32 |
| Amgen Inc. | 1 | $30 |
Products named: Mavenclad, TYSABRI, Leqembi, ZEPOSIA, Cala kIQ, KESIMPTA, UPLIZNA.
Industry payments across FL — which companies pay providers there.
